Skip to main content
. 2023 May 16;73(1):52–60. doi: 10.3164/jcbn.22-140

Fig. 2.

Fig. 2.

Inhibition of DCPIP and CoQ10 reducing activity with dicumarol and quercetin. DCPIP reduction with rat liver homogenate (A) and fraction 1 (B) and its inhibition with 100 μM of dicumarol (○) or quercetin (△). CoQ10 reduction with the rat liver homogenate (C), fraction 1 (D), fraction 3 (E), and fraction 4 (F), and its inhibition with 100 μM of dicumarol (○) or quercetin (△).